A strong association between HLA-DR4 and rheumatoid arthritis (RA) 
Rheumatoid arthritis (RA) is a relatively common disease with a worldwide distribution. In the last decade a number of studies have investigated the genetic basis for RA. One major focus of these studies has been the attempt to identify genes within the class II region of the major histocompatibility complex-that is, HLA-which confer susceptibility or resistance for the disease. A strong association between HLA-DR4 and RA has been observed in most populations studied, though several exceptions have now been reported.' In contrast; the incidence of DR2 is decreased in patients with RA, suggesting that this specificity may confer some protection against the disease.2' Evidence for the genetic susceptibility to RA also comes from the analyses of multiple case families, where HLA haplotype sharing in affected sibling pairs shows linkage of the susceptibility/resistance gene(s) to the HLA region.'
In white populations DR4 is found in about 66% of the patients with RA as compared with its incidence in 26% of healthy individuals.' Investigations of the subtypes of DR4 showed a significant increase of Dw4 and Dwl4 in white patients, and of Dwl5 in Japanese patients.5 '6 On the other hand, DR4 was not associated with RA in the Israeli population. 7 Recently, we examined the extended DR4 haplotypes in patients with RA and reported a significant increase of the DR4,DQw7 haplotype in patients with severe to moderate disease.8 9 Similarly, a significantly higher incidence of DR4,DQw7 haplotype in seropositive juvenile RA, severe forms of RA, and Felty's syndrome has also been described.' '3 Based on these observations, hypotheses for the molecular basis for associations between HLA class II antigens and RA have recently been proposed.' '6 The incidence of DR2 is significantly decreased in patients with RA as compared with normal controls.2' A number of subtypes of DR2 have been defined by serology and more finely by allorecognition in the mixed lymphocyte culture reactions. [17] [18] [19] The subtypes of DR2 include DR2 long-DRwl5 (Dw2 and Dwl2) and DR2 short-DRwl6 (Dw2l=AZH, FJO,WJR,MN2, and Dw22=DB9,LD5a). Of these, Dw2, Dwl2, and Dw2l are in linkage disequilibrium with different subspecificities of DQwl, DQwl.2(DQw6), DQwl.12(DQw6), and DQwl.AZH(DQw5), respectively. On the other hand, Dw22 is associated with DQw3-TP(DQw7).l9 DR2,DQwl haplotypes have, therefore, three subtypic (Dw2, Dw12, and Dw21) specificities. The definition and identification of these DR,DQ subspecificities have only been possible by Southern blot and nucleotide sequence analyses of cDNA clones.2123 It is evident from these data that these subspecificities of DR2,DQwl haplotypes are different at the genetic level. The distribution of these subspecificities in RA may be important for understanding the genetic basis of susceptibility/ resistance to the disease. Figure 1 shows the results from three B in TAE cell lymphoblastoid cell lines, AMAI (Dw2), mmol/l E4181324 (Dwl2), and DEM (Dw2l,DR4), with Eco RV, Bam HI, and Eco RI restriction endonucleases. Six bands, 5 2 kb (Eco RV), 2 8 kb and 6-6 kb (Bam HI), and 2-4 kb, 9-2 kb, and 9-6 kb (Eco RI), identify the DRw5(Dw2), DQw6 subtype; two bands, 11-0 kb (Eco RV) and 24- 2,3 (fig 2) and lanes 1, 2 (fig 3) ) carried the DRw15 (Dw2),DQw6 subspecificity and one patient (lane 3 (fig 3)) We recently proposed that the residue at position 57 in the DQBl chain may be important in conferring susceptibility to severe RA. 6 In addition, we suggested, on the basis ofpublished data both in man4' and in mice,42 that the specificity of the DQ molecule is determined by both DQA1 and DQBl chains. The presence of residue D at position 57 in the DQw7 BI chain together with the DR4 associated DQw7 Al chain may be important in conferring susceptibility to severe RA. The DQw haplotypes in which the negatively charged D residue at position 57 in the DQB1 chain is replaced by non-polar serine (S), valine (V), or alanine (A) may have a neutral or negative association with severe RA susceptibility. The results in this study on distribution of DR2 haplotypes in patients with RA support this hypothesis as (a) the DRwl6(Dw2l),DQw5 haplotype in which the DQB1 chain has residue S at position 57 is absent in RA, and (b) the DRwl5(Dw2,Dwl2), DQw6 haplotype with residue D in position 57 of the DQB1 chain is present in RA. As the DRwlS,DQw6 associated DQA1 chain is different from the DR4,DQw7 associated DQA1 chain it is likely that this specificity is not increased in patients with RA.
Rheumatoid arthritis is a heterogeneous disease. It is possible that both DR and DQ genes are important in conferring susceptibility to RA-DRB1 in the mild form of the disease and DQB1 in severe RA, requiring sodium aurothiomalate as a disease remitting drug. We suggest that a multifactorial approach to the study of RA may serve to illuminate the associations between HLA antigens and the disease. 
